Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03975491

The Exercise And Colorectal Cancer Treatment Trial

The Exercise And Colorectal Cancer Treatment (EXACT) Trial

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Pennington Biomedical Research Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will examine the biologic processes through which exercise may prevent disease recurrence in patients who have completed treatment for colorectal cancer.

Detailed description

This randomized trial will examine the biological effects of 12-weeks of moderate-intensity aerobic exercise versus wait-list control in 60 subjects who have completed standard medical therapy for colorectal cancer. The primary objective is to determine if aerobic exercise can reduce systemic inflammation, quantified using plasma concentrations of high-sensitivity C-reactive protein and interleukin-6. The secondary objectives are to determine if exercise can reduce: 1) insulin resistance quantified using an oral glucose tolerance test, and; 2) circulating tumor cells quantified using a microfluidic antibody-mediated capture platform. The exploratory objective is to determine if exercise can improve mitochondrial respiration rates and fatty acid oxidation in peripheral blood mononuclear cells and tumor fraction.

Conditions

Interventions

TypeNameDescription
BEHAVIORALModerate-Intensity Aerobic ExerciseThe exercise intervention will consist of moderate-intensity (50-70% age-predicted maximum heart rate) treadmill walking. All exercise sessions will begin with a five-minute warm up of slow walking, 30-60 minutes of moderate-intensity walking, and a five-minute cool down of slow walking.
BEHAVIORALWait-List ControlParticipants randomized into the wait-list control group are asked to maintain their pre-study levels of physical activity and follow the recommendations provided by their physician.

Timeline

Start date
2019-08-01
Primary completion
2023-05-01
Completion
2026-01-01
First posted
2019-06-05
Last updated
2025-09-22
Results posted
2025-09-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03975491. Inclusion in this directory is not an endorsement.